Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
Conditions: Infections; Vector Borne Diseases; Systemic Inflammatory Response Syndrome; Inflammation; Pathologic Processes; Malaria; Malaria,Falciparum; Parasitemia; Parasitic Diseases; Protozoan Infections; Antimalarials; Anti-Infective Agents Interventions: Drug: MMV367; Other: P. falciparum IBSM infection Sponsors: Medicines for Malaria Venture; GlaxoSmithKline; Southern Star Research Pty Ltd.; ICON plc; University of the Sunshine Coast; QIMR Berghofer Medical Research Institute; Queensland Paediatric Infectious Diseases (QPID) laboratory; Swiss BioQuant A.G., Switze rland Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Infectious Diseases | Laboratory Medicine | Malaria | Parasitology | Pediatrics | Research